Document is current
Any future updates will be listed below
-
Authors
Zatreanu, Diana
Robinson, Helen M. R.
Alkhatib, Omar
Boursier, Marie
Finch, Harry
Geo, Lerin
Grande, Diego http://orcid.org/0000-0001-6770-9274
Grinkevich, Vera
Heald, Robert A.
Langdon, Sophie
Majithiya, Jayesh
McWhirter, Claire http://orcid.org/0000-0003-3316-205X
Martin, Niall M. B.
Moore, Shaun
Neves, Joana
Rajendra, Eeson http://orcid.org/0000-0002-5301-054X
Ranzani, Marco
Schaedler, Theresia
Stockley, Martin
Wiggins, Kimberley
Brough, Rachel
Sridhar, Sandhya
Gulati, Aditi
Shao, Nan
Badder, Luned M.
Novo, Daniela
Knight, Eleanor G.
Marlow, Rebecca
Haider, Syed http://orcid.org/0000-0001-6685-5480
Callen, Elsa
Hewitt, Graeme
Schimmel, Joost
Prevo, Remko
Alli, Christina
Ferdinand, Amanda
Bell, Cameron
Blencowe, Peter
Bot, Chris http://orcid.org/0000-0001-6225-4047
Calder, Mathew
Charles, Mark
Curry, Jayne
Ekwuru, Tennyson http://orcid.org/0000-0003-0070-3403
Ewings, Katherine
Krajewski, Wojciech
MacDonald, Ellen
McCarron, Hollie
Pang, Leon
Pedder, Chris
Rigoreau, Laurent
Swarbrick, Martin http://orcid.org/0000-0001-6942-6067
Wheatley, Ed
Willis, Simon
Wong, Ai Ching
Nussenzweig, Andre
Tijsterman, Marcel http://orcid.org/0000-0001-8465-9002
Tutt, Andrew
Boulton, Simon J. http://orcid.org/0000-0001-6936-6834
Higgins, Geoff S.
Pettitt, Stephen J. http://orcid.org/0000-0003-3313-3857
Smith, Graeme C. M. http://orcid.org/0000-0001-8320-4057
Lord, Christopher J. http://orcid.org/0000-0002-3226-0515
-
Funding
Funding for this research was provided by:
Breast Cancer Now (CTR-Q5-Y1)
National Centre for the Replacement Refinement and Reduction of Animals in Research (NC/P001262/1)
Cancer Research UK (C30061/A24439)
- License Information
-
More Information
Article History
Received: 17 March 2021
Accepted: 30 April 2021
First Online: 17 June 2021
Competing interests
: C.J.L. received research funding from: AstraZeneca, Merck KGaA and Artios, received consultancy fees, SAB membership fees or honoraria payments from: Syncona, Sun Pharma, GLG, Merck KGaA, Vertex, AstraZeneca, Tango, 3rd Rock, Ono Pharma, ArtiosPharma Ltd, Abingworth. C.J.L. has stock in: Tango, Ovibio. C.J.L., A.T., S.J.P. and D.Z. are named inventors on patents describing the use of DNA repair inhibitors and stand to gain from their development as part of the ICR ‘Rewards to Inventors’ scheme. G.S.H. received consultancy fees from, and is a shareholder of ArtiosPharma Ltd. H.M.R.R., O.A., M.B., S.J.B., H.F., L.G., D.G., V.G., R.A.H., S.L., J.M., C.M., N.M.B.M., S.M., J.N., K.P., E.R., M.R., T.S., M.S. and G.C.M.S. are all employees and shareholders of ArtiosPharma Ltd. G.C.M.S. is a shareholder of AstraZeneca PLC. S.J.B. is a Founder Scientist of ArtiosPharma Ltd. All other authors declare no competing interests.
